Midatech Pharma PLC是一家总部位于英国的药物输送技术公司。该公司专注于改善药物的生物递送和生物分配。该公司的技术包括Q-Sphera、MidaSolve和MidaCore。 Q-Sphera 技术专注于使用三维(3D)打印技术的长效注射剂。MidaCore技术平台使用超小金纳米颗粒(GNP)药物偶联物。MidaSolve Nano Inclusion技术可溶解在氢(pH)生物势下具有最小溶解度的分子,从而扩展可用的给药途径,包括直接向肿瘤给药。它拥有大约10个早期项目的管道,其中包括 MTD211(精神分裂症,MDD)、MTD219(预防、移植排斥)、MTX223、MTX213、MTX214、MTX110(胶质母细胞瘤)、MTX110(儿童脑癌(DIPG)),MTX110(成神经管细胞瘤)和MTX114(银屑病)。
名称 | 标题 | 任期 | 年龄 |
|---|---|---|---|
| Stephen Barry Parker | Independent Non-Executive Chairman | 2022 | 68 |
| Stephen Anthony Stamp | CEO & Director | 2020 | 65 |
| Fiona Mary Powell | Company Secretary, CFO & Director | 2026 | 58 |
| Simon Turton | Senior Independent Non-Executive Director | 2014 | 59 |
| Sijmen de Vries | Independent Non-Executive Director | 2004 | 67 |
| Francesco Stellaci | Chairman of Scientific Advisory Board | - | - |
| David Male | Member of Scientific Advisory Board | - | - |
| Lorraine O'Driscoll | Member of Scientific Advisory Board | - | - |
| Soledad Penades | Member of Scientific Advisory Board | - | - |
| Daniel McCurdy | Member of Scientific Advisory Board | - | 69 |
| Michael J. Natan | Member of Scientific Advisory Board | - | - |
| Jean-Christophe Le Roux | Member of Scientific Advisory Board | - | - |
| Silke Krol | Member of Scientific Advisory Board | - | - |
| Ann Louise Merchant | Independent Non-Executive Director | 2023 | 61 |